Close

Severance Hospital Develops AI Programme to Predict Chronic Kidney Disease Risk

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

The research team at Severance Hospital has developed artificial intelligence (AI) software that can predict the risk of chronic kidney disease (CKD) using retinal examination results.

CKD is typically diagnosed when a person experiences persistent decreased kidney function or proteinuria for more than six months, with common causes including diabetes and high blood pressure. By identifying individuals at high risk for CKD early on, medical professionals can implement measures to manage the condition and potentially prevent its progression.

Recognising the challenges associated with predicting CKD when kidney function appears normal, the team at Severance Hospital developed an AI programme to assess the risk of CKD based on retinal examination results and evaluated its effectiveness.

By leveraging AI technology, the software offers an opportunity to identify high-risk groups for CKD and implement preventive measures to mitigate the onset of the disease.

CKD is often referred to as a silent disease because patients usually do not exhibit symptoms until the condition has advanced significantly. Given that there is no known cure for CKD, medical professionals emphasise the importance of prevention.

The development of this AI programme marks a significant advancement in the field of kidney disease research, as it provides a means of proactive screening and intervention.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back